BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 12768354)

  • 21. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
    Ferraro L; Fuxe K; Agnati L; Tanganelli S; Tomasini MC; Antonelli T
    Synapse; 2005 Mar; 55(4):230-41. PubMed ID: 15668907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate.
    Dawson LA; Nguyen HQ; Li P
    Br J Pharmacol; 2000 May; 130(1):23-6. PubMed ID: 10780993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
    Kamińska K; Gołembiowska K; Rogóż Z
    Pharmacol Rep; 2013; 65(5):1144-51. PubMed ID: 24399710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
    Johansson D; Falk A; Marcus MM; Svensson TH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.
    Piacentini MF; Clinckers R; Meeusen R; Sarre S; Ebinger G; Michotte Y
    Life Sci; 2003 Sep; 73(19):2433-42. PubMed ID: 12954452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
    Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
    Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
    Anneken JH; Gudelsky GA
    Neuropharmacology; 2012 Nov; 63(6):1022-7. PubMed ID: 22842073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
    Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
    Roberts C; Boyd DF; Middlemiss DN; Routledge C
    Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.